C
Carola Grönhagen-Riska
Researcher at Helsinki University Central Hospital
Publications - 146
Citations - 11223
Carola Grönhagen-Riska is an academic researcher from Helsinki University Central Hospital. The author has contributed to research in topics: Transplantation & Kidney disease. The author has an hindex of 46, co-authored 146 publications receiving 10549 citations. Previous affiliations of Carola Grönhagen-Riska include University of Helsinki.
Papers
More filters
Journal ArticleDOI
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Colin Baigent,Martin J Landray,Christina Reith,Jonathan Emberson,David C. Wheeler,Charles R.V. Tomson,Christoph Wanner,Vera Krane,Alan Cass,Jonathan C. Craig,Bruce Neal,Lixin Jiang,Lai Seong Hooi,Adeera Levin,Lawrence Y. Agodoa,Mike Gaziano,Bertram L. Kasiske,Robert J. Walker,Ziad A. Massy,Bo Feldt-Rasmussen,Udom Krairittichai,Vuddidhej Ophascharoensuk,Bengt Fellström,Hallvard Holdaas,Vladimir Tesar,Andrzej Wiecek,Diederick E. Grobbee,Dick de Zeeuw,Carola Grönhagen-Riska,Tanaji Dasgupta,David Lewis,William G. Herrington,Marion Mafham,William Majoni,K Wallendszus,Richard H. Grimm,Terje R. Pedersen,Jonathan A. Tobert,Jane Armitage,Alex Baxter,Christopher Bray,Yiping Chen,Zhengming Chen,Michael Hill,Carol Knott,Sarah Parish,David Simpson,Peter Sleight,Alan Young,Rory Collins +49 more
TL;DR: Reduction of LDL cholesterol with simvastatin 20 mg plus ezetimibe 10 mg daily safely reduced the incidence of major atherosclerotic events in a wide range of patients with advanced chronic kidney disease.
Journal ArticleDOI
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
Bengt Fellström,Alan G. Jardine,Roland E. Schmieder,Hallvard Holdaas,Kym M. Bannister,J.J. Beutler,Dong Wan Chae,Alejandro Chevaile,Stuart M. Cobbe,Carola Grönhagen-Riska,José Jayme Galvão de Lima,Robert L. Lins,Gert Mayer,Alan W. McMahon,Hans-Henrik Parving,Hans-Henrik Parving,Giuseppe Remuzzi,Ola Samuelsson,Sandor Sonkodi,Gultekin Suleymanlar,Dimitrios Tsakiris,Vladimir Tesar,Vasil Todorov,Andrzej Wiecek,Rudolf P. Wüthrich,Mattis Gottlow,Eva Johnsson,Faiez Zannad +27 more
TL;DR: In patients undergoing hemodialysis, the initiation of treatment with rosuvastatin lowered the LDL cholesterol level but had no significant effect on the composite primary end point of death from cardiovascular causes, nonf fatal myocardial infarction, or nonfatal stroke.
Journal ArticleDOI
Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial
Hallvard Holdaas,Bengt Fellström,Alan G. Jardine,Ingar Holme,Gudrun Nyberg,Per Fauchald,Carola Grönhagen-Riska,Søren Madsen,Hans-Hellmut Neumayer,Edward S. Cole,Bart Maes,Patrice M. Ambühl,Anders G. Olsson,Anders Hartmann,D. Solbu,Terje R. Pedersen +15 more
TL;DR: Overall effects of fluvastatin were similar to those of statins in other populations, and seemed to be reduced in cardiac deaths and non-fatal MI, but did not generally reduce rates of coronary intervention procedures or mortality.
Journal Article
Corneal structure and sensitivity in type 1 diabetes mellitus.
Maria E. Rosenberg,Timo Tervo,Ilkka Immonen,Linda J. Müller,Carola Grönhagen-Riska,Minna H Vesaluoma +5 more
TL;DR: According to this study, the cornea becomes thicker in a relatively early stage of diabetes but does not further change with the degree of neuropathy, and confocal microscopy appears to allow early detection of beginning neuropathy.
Journal ArticleDOI
Renal replacement therapy in Europe: the results of a collaborative effort by the ERA–EDTA registry and six national or regional registries
Paul C. W. van Dijk,Kitty J Jager,Frank de Charro,Frederic Collart,Ronald Cornet,Friedo W. Dekker,Carola Grönhagen-Riska,Reinhard Kramar,Torbjørn Leivestad,Keith Simpson,J. Douglas Briggs +10 more
TL;DR: The ERA-EDTA registry as discussed by the authors collects data from national and regional registries of Austria, Finland, French-Belgium, The Netherlands, Norway, and Scotland for renal replacement therapy (RRT) treatment.